ARL researchers acknowledged for first-ever peptide biomaterial discovery | Mutant-flu researchers appeal Dutch court ruling on export permits | MERS case reported in Oman; French case ruled out | Nanotube-based sensors can be implanted under the skin for a year | NIH scientists develop candidate vaccine against respiratory syncytial virus | What we get wrong about small business | Electronic devices that biodegrade to order could lead to huge medical advances | Battling biological warfare | Rift widens over structure of HIV’s molecular anchor | USDA’s poultry inspection system needs to be modernized | NIH awards 17M in grants to augment genomics research in Africa | DoD announces positive results for flu treatment drug | ‘Flipping the switch’ reveals new compounds with antibiotic potential
See what we’re reading this week at Global Biodefense on topics like progress on pandemic flu vaccines, dissolving medical devices, ARL peptide discovery and more…
ARL researchers acknowledged for first-ever peptide biomaterial discovery (AWS)
Mutant-flu researchers appeal Dutch court ruling on export permits (Nature)
MERS case reported in Oman; French case ruled out (CIDRAP)
Nanotube-based sensors can be implanted under the skin for a year (MIT)
NIH scientists develop candidate vaccine against respiratory syncytial virus (NIH)
What we get wrong about small business (The Atlantic)
Electronic devices that biodegrade could lead to huge medical advances (Guardian)
Battling biological warfare (Armed with Science)
Rift widens over structure of HIV’s molecular anchor (Nature)
USDA’s poultry inspection system needs to be modernized (Food Safety News)
NIH awards 17M in grants to augment genomics research in Africa (NIH)
DoD announces positive results for flu treatment drug (PR Newswire)
‘Flipping the switch’ reveals new compounds with antibiotic potential (OSU)
